Quick Answer
Advanced Biomed Inc. reported Net Income of -$3.26 million for fiscal year 2025.
Advanced Biomed Inc. — Key Financials by Year
| Metric | 2025 | 2024 | 2023 |
|---|---|---|---|
| Net Income | -$3.26M -17.1% |
-$2.78M | — |
| Diluted EPS | -$0.16 -14.3% |
-$0.14 | — |
| Total Assets | $6.51M +46.0% |
$4.46M | — |
| Stockholders Equity | $3.48M +109.1% |
$1.66M +27.4% |
$1.31M |
| R&D Expense | $909.8K +3.4% |
$880.2K | — |
| Shares Outstanding | 21.64M +8.2% |
20.00M -80.0% |
100.00M |
Most Recent Quarter
| Metric | Quarter Ending | Value | YoY | QoQ |
|---|---|---|---|---|
| Net Income | December 31, 2025 | $6.86M | +855.4% | +1872.5% |
| Diluted EPS | December 31, 2025 | $0.31 | +720.0% | +1650.0% |
| Total Assets | December 31, 2025 | $10.85M | +140.9% | +73.8% |
| Stockholders Equity | December 31, 2025 | $9.48M | +1431.7% | +215.6% |
| R&D Expense | December 31, 2025 | $186.3K | -12.3% | -21.0% |
| Shares Outstanding | December 31, 2025 | 21.64M | +8.2% | +0.0% |
- Advanced Biomed Inc. reported Net Income of -$3.26 million for fiscal year 2025.
- Advanced Biomed Inc. showed a decrease of -17.1% in Net Income compared to the prior fiscal year.
- Advanced Biomed Inc. reported Diluted EPS of $0.16 per share (loss) for fiscal year 2025.
- Advanced Biomed Inc. showed a decrease of -14.3% in Diluted EPS compared to the prior fiscal year.
- Advanced Biomed Inc. reported Total Assets of $6.51 million for fiscal year 2025.
- Advanced Biomed Inc. showed an increase of +46.0% in Total Assets compared to the prior fiscal year.
- Advanced Biomed Inc. reported Stockholders Equity of $3.48 million for fiscal year 2025.
- Advanced Biomed Inc. showed an increase of +109.1% in Stockholders Equity compared to the prior fiscal year.
- Advanced Biomed Inc. reported R&D Expense of $909.8 thousand for fiscal year 2025.
- Advanced Biomed Inc. showed an increase of +3.4% in R&D Expense compared to the prior fiscal year.
- Advanced Biomed Inc. reported Shares Outstanding of 21.64 million shares for fiscal year 2025.
- Advanced Biomed Inc. showed an increase of +8.2% in Shares Outstanding compared to the prior fiscal year.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: